Assembly Biosciences Inc (NASDAQ: ASMB) stock suffered a major decline of -16.3% on 9/23/24. The shares closed at $16.26. Moreover, this decline was accompanied by exceptionally high trading volume at 501% of normal. The stock has declined -10.0% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
ASMB’s future returns on capital are forecasted to be in line with the cost of capital. Accordingly, the company is expected to continue to be Value Creation neutral.
Assembly Biosciences has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. Assembly Biosciences has a very low Appreciation Score of 5 but a very high Power Rating of 93, producing the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment